Search

RESEARCH

University of Cambridge | Professor Nicholas Morrell

Pulmonary arterial hypertension (PAH) is a rare but severe disease caused by the narrowing and loss of blood vessels in the lung. People with PAH experience severe breathlessness, even when resting. Patients may need a lung or heart and lun...

RESEARCH

Queen's University Belfast | Professor Alan Stitt

Belfast researchers are part of the global research effort to boost the body’s own repair systems to combat circulatory diseases. A major global research effort is underway to help the body to repair and/or grow new blood vessels to preve...

RESEARCH

University of Oxford | Professor Rebecca Sitsapesan

Atrial fibrillation (AF), a common heart rhythm disturbance, is a major risk factor for having a stroke, as well as causing shortness of breath and dizziness in patients. In AF, the heartbeat becomes irregular. The exact causes are not well...

A report from Fraser of Allander Institute and commissioned by the British Heart Foundation, found that investment by the third sector plays a vital role in both the health of the nation and the economy.

The Chancellor announced investments for the NHS and research and development in yesterday’s Spending Review. We were pleased to see health prioritised and hope that this translates into better care for heart patients as well as more funding for lifesaving research.

Discover 25 herbs and spices that are wonderful alternatives to salt and sugar. Take your cooking to a new level while keeping your heart healthy.

Looking for a heart-healthy meal you can cook in batches? Discover our easy recipes you can freeze for later, including butternut squash, minestrone and chicken noodle soup.

RESEARCH

University of Leeds | Professor Robert Ariens

Coronary heart disease claims thousands of lives each year in the UK. The coronary arteries of people with the disease have been damaged by the build-up of ‘fatty plaques’ in the vessel wall, which can eventually rupture to cause a blood cl...

Last night, our associate medical director, Dr Sonya Babu-Narayan was recognised by Charity Comms at the Inspiring Communicators Awards for her hard work in campaigning for the rights of heart patients during and in the aftermath of the COVID-19 pandemic.

A common antiparasitic drug could block lung damage in people with coronavirus, according to new research part-funded by us and published in Nature.